Literature DB >> 32561462

The immunologic etiology of psychiatric manifestations in systemic lupus erythematosus: A narrative review on the role of the blood brain barrier, antibodies, cytokines and chemokines.

Sander J Deijns1, Jasper C A Broen2, Nyika D Kruyt3, Chris D Schubart4, Laura Andreoli5, Angela Tincani6, Maarten Limper7.   

Abstract

INTRODUCTION: The aim of this narrative review is to provide an overview of the literature on the possible immunologic pathophysiology of psychiatric manifestations of neuropsychiatric systemic lupus erythematosus (NPSLE).
METHODS: A systematic search on PubMed was conducted. English studies with full text availability that investigated the correlation between blood-brain barrier (BBB) dysfunction, intrathecal synthesis of antibodies, antibodies, cytokines, chemokines, metalloproteinases, complement and psychiatric NPSLE manifestations in adults were included.
RESULTS: Both transient BBB-dysfunction with consequent access of antibodies to the cerebrospinal fluid (CSF) and intrathecal synthesis of antibodies could occur in psychiatric NPSLE. Anti-phospholipid antibodies, anti-NMDA antibodies and anti-ribosomal protein p antibodies seem to mediate concentration dependent neuronal dysfunction. Interferon-α may induce microglial engulfment of neurons, direct neuronal damage and production of cytokines and chemokines in psychiatric NPSLE. Several cytokines, chemokines and matrix metalloproteinase-9 may contribute to the pathophysiology of psychiatric NPSLE by attracting and activating Th1-cells and B-cells. DISCUSSION: This potential pathophysiology may help understand NPSLE and may have implications for the diagnostic management and therapy of psychiatric NPSLE. However, the presented pathophysiological model is based on correlations between potential immunologic etiologies and psychiatric NPSLE that remain questionable. More research on this topic is necessary to further elucidate the pathophysiology of NPSLE.
Copyright © 2020. Published by Elsevier B.V.

Entities:  

Keywords:  Antibody; Blood-brain barrier; Chemokine; Cytokine; Neuropsychiatric systemic lupus erythematosus; Psychiatric

Year:  2020        PMID: 32561462     DOI: 10.1016/j.autrev.2020.102592

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  5 in total

1.  A Study of IFN-α-Induced Chemokines CCL2, CXCL10 and CCL19 in Patients with Systemic Lupus Erythematosu.

Authors:  Mariela Gencheva Geneva-Popova; Stanislava Dimitrova Popova-Belova; Petya Nikolova Gardzheva; Krasimir Iliev Kraev
Journal:  Life (Basel)       Date:  2022-02-08

Review 2.  Motor neuron disease in a patient with overlap syndrome (rheumatoid arthritis; systemic lupus erythematosus, Sjogren's syndrome).

Authors:  Ebru Atalar; Fatma Gül Yurdakul; Kevser Gök; Tuba Güler; Şükran Erten; Evren Yaşar; Hatice Bodur
Journal:  Rheumatol Int       Date:  2022-09-18       Impact factor: 3.580

Review 3.  Follicular Regulatory T Cells in Systemic Lupus Erythematosus.

Authors:  Xin Xia; Jun Yang; Shengjun Wang
Journal:  J Immunol Res       Date:  2021-07-13       Impact factor: 4.818

4.  Autoimmune encephalitis: the first observational study from Iran.

Authors:  Masoud Etemadifar; Ali Aghababaei; Hosein Nouri; Parisa K Kargaran; Shaghayegh Mohammadi; Mehri Salari
Journal:  Neurol Sci       Date:  2021-07-30       Impact factor: 3.830

Review 5.  Autoantibodies in Neuropsychiatric Systemic Lupus Erythematosus (NPSLE): Can They Be Used as Biomarkers for the Differential Diagnosis of This Disease?

Authors:  Elias Manca
Journal:  Clin Rev Allergy Immunol       Date:  2021-06-11       Impact factor: 10.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.